Black Opal IPO: Pricing, Financials, and Expert Review
Black Opal Consultants is hitting the BSE SME platform with a Rs. 55.08 crore combo offer. We break down the financials, valuation, and what the deal…
Live Grey Market Premium
Today's IPO GMP, subscription figures, and estimated listing gains.
| Company | Price band | GMP | Est. listing | Status |
|---|---|---|---|---|
|
Black Opal Sme |
₹0–₹0 | ₹0 (0.0%) | ₹0 | Listed |
|
Pind Hospitality Sme |
₹0–₹0 | ₹0 (0.0%) | ₹0 | Listed |
|
Q-Line Biotech Sme |
₹0–₹0 | ₹0 (0.0%) | ₹0 | Listed |
GMP figures reflect unofficial grey-market trading and can change quickly — not a guaranteed listing price.
Latest analysis
Visit the blog
Q-Line Biotech IPO: Valuation, Financials, and Expert Review
Q-Line Biotech is raising Rs. 214.48 crore via an SME IPO on NSE Emerge. Read our…
Q-Line Biotech IPO: Valuation, Financials, and Expert Review
Q-Line Biotech is raising Rs. 214.48 crore via a maiden SME IPO on NSE Emerge. Read…
Q-Line Biotech IPO: Valuation, Financials, and Expert Review
An in-depth look at Q-Line Biotech Ltd's maiden SME IPO, analyzing its diagnostics business, erratic earnings,…
Understanding the numbers
What is GMP?
The price IPO shares trade at in the unofficial grey market before listing — the premium over the issue price reflects unofficial demand, not a guaranteed price.
Why subscription matters more
QIB (institutional) subscription is the more reliable signal — institutions do deep diligence before bidding. High GMP with weak QIB demand is worth a second look.
How to read this table
Est. listing = price band top + current GMP. It's an estimate, not a forecast — GMP can and does swing right up to listing day.